From Ore to Gold Bars-This Nevada Mine Is Already Producing
Most juniors explore...Few actually produce. This one's already pouring gold thanks to infrastructure that would cost tens of millions to build today. With major land holdings and room to scale, it's one to watch. Discover the little known gold company that's already producing.
Skye Bioscience Advances Position In Competitive Obesity Market With Promising Data
Skye Bioscience's latest data show nimacimab boosted tirzepatide's weight loss effects and reduced obesity treatment rebound risk.
Social Security whistleblower who claims DOGE mishandled Americans' sensitive data resigns from post
WASHINGTON (AP) — A Social Security official who has filed a whistleblower complaint alleging the Department of Government Efficiency officials Americans' sensitive information says he's resigning his post because of actions taken against him since making his complaint.
Is This Elon's Worst Nightmare? - Ad
Elon's empire looks doomed - crashing sales, lost tax credits, and media backlash. But behind the scenes, Tesla is about to unleash a breakthrough Forbes calls a "multi-trillion-dollar opportunity." It's not the end - it's the start of a 25,000% AI comeback.
Salmonella outbreak tied to recalled eggs has sickened 95 people since January
At least 95 people in more than a dozen states have been sickened since January in an outbreak of salmonella poisoning tied to recalled eggs, federal health officials
Robert Kennedy Jr. Packs CDC Panel With Vaccine Skeptics Ahead of Key Vote On COVID-19 Shots
Health and Human Services Secretary Robert F. Kennedy Jr. has added five new members to the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices, just days before it reconvenes to vote on COVID-19 shots and other routine pediatric vaccine recommendations.
Gold Is Being Reintroduced Into the Monetary System - Ad
While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.
FDA Expands Krystal Biotech Vyjuvek's Label Allowing Newborns Access To Gene Therapy For Blistering Skin
The FDA approved Krystal Biotech's Vyjuvek label update, expanding treatment to newborns and offering flexible wound care based on real-world patient data.
Tempus AI Gains FDA Clearance For Updated Pixel To Boost Accuracy And Efficiency In Cardiac Imaging
Tempus AI's Tempus Pixel received FDA clearance for cardiac imaging updates, adding T1/T2 maps to enhance MR image analysis and diagnosis precision.
The $25M Contract Nobody Is Talking About - Ad
One deal alone covers the entire valuation of this overlooked stock. And more contracts are already stacking up in Europe and the US.
Ionis Pharmaceuticals To Expedite Development Of Rare Neurological Disease Candidate With FDA Breakthrough Status
FDA designates Ionis Breakthrough Therapy for Angelman syndrome after Phase 1/2 results showed functional improvements.
Large Patient Population Is Key Driver For Bright Minds' Growth
BTIG initiates coverage on Bright Minds Biosciences with a Buy rating, citing BMB‑101's potential and key Phase 2 data expected by the end of 2025
Analysts Project This Stock Could Jump to $14 a Share. You Can Still Invest for $3.50. - Ad
The AI company making heart disease easier to detect is offering investors $3.50 investment units that include one convertible preferred share and one warrant, providing investors with access to 2 common shares. Based on analyst 1- year projections, that amounts to a near-term 500% return potential.
Regenxbio Unveils 12-Month Data For Gene Therapy Soon After FDA Delays Review Date
Regenxbio reported sustained biomarker reduction and positive neurodevelopmental outcomes in the pivotal CAMPSIITE trial of RGX-121 for MPS II.
These neurodivergent students are helping each other build more inclusive schools
DENVER (AP) — Engineering student Tory Ridgeway buried his head.
Scarcity Meets Momentum - Ad
With insiders and institutions holding most of the float, just 9.7M shares are truly available. New contracts could ignite moves that Wall Street can't ignore.
Why Is GSK Partner Wave Life Sciences Stock Trading Lower On Wednesday?
Wave Life Sciences shares early WVE-006 trial results in alpha-1 antitrypsin deficiency, reporting durable protein production and favorable safety.
This Merck Pill Promises Powerful Cholesterol Reduction Without Injections
Merck's Coralreef Lipids trial showed enlicitide cut LDL-C and other lipid markers, while pooled Verquvo data hinted at heart failure benefits.
From Ore to Gold Bars-This Nevada Mine Is Already Producing - Ad
Most juniors explore...Few actually produce. This one's already pouring gold thanks to infrastructure that would cost tens of millions to build today. With major land holdings and room to scale, it's one to watch. Discover the little known gold company that's already producing.
Trump's new CDC chief: A Washington health insider with a libertarian streak
WASHINGTON (AP) — President Donald Trump has picked Jim O’Neill, a former investor and critic of health regulations serving under Health Secretary Robert F. Kennedy Jr., to take control of the Centers for Disease Control and Prevention, following a tumultuous week in which the agency's director was forced out.
Novo Nordisk Slowdown Weighs On Denmark's Economic Outlook
Novo Nordisk alone contributing one-fifth of employment gains to Denmark. But economic headwinds are mounting.
Why Are Wall Street Insiders Moving Their Money to This One Asset? - Ad
Something far more consequential for your money than tariffs is unfolding behind the scenes... Tucked inside this overlooked directive is a plan set to be executed for the first time in in U.S. history. One Stansberry Research's Senior Partner says it's set to trigger a rare window for potentially explosive gains in ONE asset immediately. (Not AI or crypto). Wall Street insiders are already positioning themselves... and he insists you should, too, before it's too late.
Fire departments concerned about cancer risks are buying gear that is free of forever chemicals
EAST PROVIDENCE, R.I. (AP) — Every time he rushed out on a fire call, East Providence Lt. Thomas Votta knew he put himself at risk for cancer. There are potential carcinogens in the smoke billowing out of a house fire, but also risks from wearing his .
Stock Of The Day: Another Breakout For Eli Lilly?
Shares of Eli Lilly (LLY) are testing a resistance level. If they can break through this resistance, a large more higher may follow.
This Gold Miner Has the Map, the Metal, and the Momentum - Ad
JPMorgan is forecasting that gold will push past $4,000, and this Nevada operation is positioned to benefit. Historical estimates show its property could hold around 1.8 million ounces of measured and indicated gold, backed by infrastructure and billionaire investors. The company's already producing, refining gold onsite and looking to expand. That's not a dream-stage story-that's a head start.
CDC dramatically scales back program that tracks food poisoning infections
Federal health officials have dramatically scaled back a program that has tracked food poisoning infections in the U.S. for three decades.
Nonalcoholic beer and mocktails can help people stay sober or drink less, but are not for everyone
Several years into her sobriety, Logan Denzer decided to try while others around her drank real .
The Next Palantir Moment Could Be Here - Ad
A $21M market cap company is landing multimillion-dollar contracts with banks and governments. With only 9.7M shares in the float, scarcity could spark explosive moves.
Marker Therapeutics Stock Drops After Report About Lymphoma Treatment
Marker Therapeutics reports strong safety and efficacy data for MT-601 in lymphoma patients, with durable responses and no serious adverse events.
Takeaways from scientists on the Trump administration's work on climate change and public health
WASHINGTON (AP) — A Trump administration proposal to reverse a landmark finding that climate change is dangerous to the public relies heavily on a report from the Department of Energy that dozens of scientists say is flawed.
The Roadmap to $100M+ Revenue - Ad
Recurring deals, Tier-1 banks, and expansion into new markets put this company on track to triple revenue by 2026. Yet the market cap is still just $21M.
FDA Flags Alarming Contamination At Novo Nordisk Indiana Plant, Including Cat Hair, Bacteria, And Foreign Particles
Novo Nordisk's acquired facility faces scrutiny over recurring contamination, incomplete investigations, and ineffective corrective actions.
BeOne Cashes In On Amgen's Cancer Drug Royalties In Multibillion-Dollar Pharma Tie-Up
BeOne Medicines will sell global Imdelltra royalties to Royalty Pharma for up to $950 million while retaining rights to other oncology programs with Amgen.
Is This Elon's Worst Nightmare? - Ad
Elon's empire looks doomed - crashing sales, lost tax credits, and media backlash. But behind the scenes, Tesla is about to unleash a breakthrough Forbes calls a "multi-trillion-dollar opportunity." It's not the end - it's the start of a 25,000% AI comeback.
Apply safety rules to more trains carrying flammable cargo, lawmakers urge
When a BNSF freight train carrying six cars of liquefied petroleum gas derailed near Manuelito, New Mexico, in 2024, the resulting fire shut down more than 100 miles of an interstate highway.
Students face new cellphone restrictions in 17 states as school year begins
Jamel Bishop is seeing a big change in his classrooms as he begins his senior year at Doss High School in Louisville, Kentucky, where cellphones are now banned during instructional time.
Gold Is Being Reintroduced Into the Monetary System - Ad
While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.
Anavex Life Pre-Treatment Prevented Cognitive Impairment In Animal Model of Alzheimer's Disease, New Publication Shows
Anavex published data showing blarcamesine prevented amyloid-related brain damage in mice, supporting SIGMAR1 as a target for Alzheimer's prevention.
Minnesota sues TikTok, alleging it preys on young people with addictive algorithms
ST. PAUL, Minn. (AP) — Minnesota on Tuesday joined a wave of , alleging the social media giant preys on young people with addictive algorithms that trap them into becoming compulsive consumers of its short videos.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.